Horizon Blue Cross and Blue Shield of New Jersey policies, page 6

Search Horizon Blue Cross and Blue Shield of New Jersey's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

834 public policies Substrate tracks for Horizon Blue Cross and Blue Shield of New Jersey, by title.

Horizon Blue Cross and Blue Shield of New Jersey policies
PolicyDetailsCodesSource
Extracranial Carotid Artery StentingCommercial—Original policy ↗
Eyelid Thermal Pulsation for the Treatment of Dry Eye SyndromeCommercial, Medicaid—Original policy ↗
Facet ArthroplastyEffective Feb 18, 2020 · Commercial—Original policy ↗
Facet Joint Injections/Medial Branch BlocksCMM-201 · Commercial—Original policy ↗
False ClaimsEffective Jan 1, 2007 · Medicaid—Original policy ↗
Fecal Analysis in the Diagnosis of Intestinal DysbiosisEffective Oct 14, 2019 · Commercial—Original policy ↗
Fecal Calprotectin TestingEffective Nov 12, 2019 · Commercial—Original policy ↗
Fecal Microbiota TransplantationCommercial, Medicaid2Original policy ↗
Female Hormones (Non-Oral Hormonal Contraceptives, Oral Contraceptives, Implantable Estrogens)Commercial—Original policy ↗
Fetal Surgery for Prenatally Diagnosed MalformationsCommercial, Medicaid—Original policy ↗
Fluency Enhancing Devices for StutteringCommercial, Medicaid—Original policy ↗
Focal Treatments for Prostate CancerCommercial, Medicaid—Original policy ↗
Foot Care ServicesCommercial, Medicaid—Original policy ↗
Free Flap Breast ReconstructionEffective Nov 15, 2021 · Commercial, Medicaid4Original policy ↗
Frequency of Care Coordination Services and ESRD ProceduresEffective Feb 25, 2019 · Commercial8Original policy ↗
Frequency of G0179Effective Feb 25, 2019 · Commercial, Medicaid1Original policy ↗
Fulvestrant (Faslodex)Commercial—Original policy ↗
Functional Endoscopic Sinus Surgery for Chronic RhinosinusitisCommercial, Medicaid—Original policy ↗
G2211 Add-on CodeEffective Jan 1, 20241Original policy ↗
Gait Analysis for Cerebral Palsy and Other ConditionsCommercial, Medicaid—Original policy ↗
Gait Trainers and Standing FramesCommercial, Medicaid7Original policy ↗
Gas Permeable Scleral Contact LensCommercial, Medicaid1Original policy ↗
Gastric Electrical StimulationCommercial, Medicaid—Original policy ↗
Gaucher Disease TherapyCommercial1Original policy ↗
Gazyva (Obinutuzumab)Commercial—Original policy ↗
Gemcitabine in sodium chloride injection (Infugem)Commercial—Original policy ↗
Gemtuzumab Ozogamicin (Mylotarg)Commercial—Original policy ↗
Gender Reassignment/Gender Affirming SurgeryCommercial, Medicaid—Original policy ↗
Gene Expression Profile Testing and Circulating Tumor DNA Testing for Predicting Recurrence in Colon CancerEffective Aug 1, 2017 · Commercial, Medicaid1Original policy ↗
Gene Expression Profiling and Protein Biomarkers for Prostate Cancer ManagementCommercial—Original policy ↗
Gene Expression Profiling for Cutaneous MelanomaCommercial—Original policy ↗
Gene Expression Profiling for Uveal MelanomaCommercial—Original policy ↗
Gene Expression Testing in the Evaluation of Patients With Stable Ischemic Heart DiseaseEffective Aug 1, 2017 · Commercial, Medicaid—Original policy ↗
Gene Expression-Based Assays for Cancers of Unknown PrimaryCommercial3Original policy ↗
General Approach to Evaluating the Utility of Genetic PanelsCommercial—Original policy ↗
General Approach to Genetic TestingCommercial—Original policy ↗
General Guideline for Advanced Imaging StudiesCommercial, Medicaid1Original policy ↗
General Guideline for the Delineation of Medical vs. Dental and Accidental Dental BenefitsCommercial, Medicaid—Original policy ↗
Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate CancerCommercial—Original policy ↗
Genetic Cancer Susceptibility PanelsCommercial—Original policy ↗
Genetic Testing for Alpha-ThalassemiaCommercial4Original policy ↗
Genetic Testing for Alpha1-Antitrypsin DeficiencyCommercial—Original policy ↗
Genetic Testing for Alzheimer DiseaseCommercial—Original policy ↗
Genetic Testing for BRCA1 or BRCA2 for Hereditary Breast/Ovarian Cancer Syndrome and Other High-Risk CancersCommercial—Original policy ↗
Genetic Testing for CADASIL SyndromeCommercial, Medicaid—Original policy ↗
Genetic Testing for Cardiac Ion ChannelopathiesCommercial2Original policy ↗
Genetic Testing for CHARGE SyndromeCommercial—Original policy ↗
Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital AnomaliesCommercial5Original policy ↗
Genetic Testing for Diagnosis and Management of Mental Health ConditionsCommercial, Medicaid1Original policy ↗
Genetic Testing for Duchenne and Becker Muscular DystrophyCommercial1Original policy ↗

Back to Horizon Blue Cross and Blue Shield of New Jersey

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.